Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Por Duvic, Madeleine, Talpur, Rakshandra, Ni, Xiao, Zhang, Chunlei, Hazarika, Parul, Kelly, Cecilia, Chiao, Judy H., Reilly, John F., Ricker, Justin L., Richon, Victoria M., Frankel, Stanley R.
Publicado em 2007

Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis

Por Dubey, Divyanshu, Pittock, Sean J., Kelly, Cecilia R., McKeon, Andrew, Lopez-Chiriboga, Alfonso Sebastian, Lennon, Vanda, Gadoth, Avi, Smith, Carin Y., Bryant, Sandra C., Klein, Christopher J., Aksamit, Allen J., Toledano, Michel, Boeve, Bradley F., Tilemma, Jan Mendelt, Flanagan, Eoin P
Publicado no Ann Neurol (2018)